In vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefazolin, cefovecin, doxycycline and pradofloxacin over a range of bacterial densities.
Bacterial densities likely fluctuate during infection and may exceed the bacterial density used in susceptibility testing. As such, investigation of bacterial killing by antibiotics over a range of varying bacterial densities may provide important differences between compounds and could impact drug selection for therapy. No animals were used. Bacterial strains collected from dogs with urinary tract infections were studied. To measure killing of clinical isolates of S. pseudintermedius and E. coli by cefazolin, cefovecin, doxycycline and pradofloxacin at clinically relevant (minimum inhibitory, mutant prevention, maximum serum and maximum tissue) drug concentrations against varying densities of bacteria. High bacterial densities ranging from 106 -109 cfu/ml were exposed to minimum inhibitory, mutant prevention, blood and tissue drug concentrations and the percentage (log10 ) viable cells killed following 30 min, 1, 2, 4, 6, 12 and 24 hours of drug exposure. Doxycycline exhibited bacteriostatic properties with less killing than the other three agents. For example, at a 107 cfu/ml density of S. pseudintermedius, more cells were killed by pradofloxacin (p<0.0001) and cefovecin (p=0.0014) but not cefazolin when compared to doxycycline at the maximum serum drug concentration than by doxycycline following 12 hours of drug exposure. Differences were seen between some drugs in the speed and extent of bacterial killing and this could be clinically important and may impact drug selection and length of therapy.